Artificial intelligence in the diagnosis of uveal melanoma: advances and applications.

Advancements in machine learning and deep learning have the potential to revolutionize the diagnosis of melanocytic choroidal tumors, including uveal melanoma, a potentially life-threatening eye cancer. Traditional machine learning methods rely heavily on manually selected image features, which can limit diagnostic accuracy and lead to variability in results. In contrast, deep learning models, particularly convolutional neural networks (CNNs), are capable of automatically analyzing medical images, identifying complex patterns, and enhancing diagnostic precision. This review evaluates recent studies that apply machine learning and deep learning approaches to classify uveal melanoma using imaging modalities such as fundus photography, optical coherence tomography (OCT), and ultrasound. The review critically examines each study's research design, methodology, and reported performance metrics, discussing strengths as well as limitations. While fundus photography is the predominant imaging modality being used in current research, integrating multiple imaging techniques, such as OCT and ultrasound, may enhance diagnostic accuracy by combining surface and structural information about the tumor. Key limitations across studies include small dataset sizes, limited external validation, and a reliance on single imaging modalities, all of which restrict model generalizability in clinical settings. Metrics such as accuracy, sensitivity, and area under the curve (AUC) indicate that deep learning models have the potential to outperform traditional methods, supporting their further development for integration into clinical workflows. Future research should aim to address current limitations by developing multimodal models that leverage larger, diverse datasets and rigorous validation, thereby paving the way for more comprehensive, reliable diagnostic tools in ocular oncology.